ResCure Pharma
Preventing Breast Cancer Recurrence
Health Tech & Life Sciences
Non Active, Aug 2018
Company Overview
Snapshot
Founded in March 2015 by Dalit Barkan, ResCure Pharma operates with 1–10 employees. The company is in the Pre-Funding stage, focusing on developing novel therapies for breast cancer recurrence.
Business overview
ResCure Pharma is a Health Tech & Life Sciences company specializing in the discovery and development of therapies to prevent and treat breast cancer recurrence. The company's core technology involves a novel platform for identifying potential compounds to combat metastatic breast cancer, serving the pharmaceutical and healthcare industries, particularly targeting patients at risk of recurrence.
Log in to access full profile ›Company Intelligence Q&A
- What is ResCure Pharma's primary focus?
- ResCure Pharma is focused on developing novel platform technology for the discovery and development of therapies aimed at preventing and treating breast cancer recurrence.
- When was ResCure Pharma founded?
- ResCure Pharma was founded in March 2015.
- Who is a key founder of ResCure Pharma?
- Dalit Barkan is a scientific founder of ResCure Pharma.
- What stage of funding is ResCure Pharma currently in?
- ResCure Pharma is currently in the Pre-Funding stage, indicating it is seeking initial investment to advance its research and development efforts in novel breast cancer therapies.
- What is the primary challenge ResCure Pharma aims to address?
- ResCure Pharma aims to address the challenge of breast cancer recurrence, particularly metastatic disease, for which there is currently no effective treatment to eradicate it once it emerges.